Idexx Laboratories Current Debt increased by 100.0% to $150.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.2%, from $170.93M to $150.00M. Over 5 years (FY 2020 to FY 2025), Current Debt shows an upward trend with a 8.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase signals a looming requirement for cash or a need to refinance existing debt in the near term.
The segment of a company's total long-term debt obligations that is scheduled for repayment within the upcoming fiscal y...
This metric is compared against current assets to determine if the company can meet its immediate debt obligations without external financing.
current_portion_long_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $124.98M | $74.99M | $75.00M | $0.00 | $0.00 | $0.00 | $74.98M | $74.99M | $74.99M | $149.99M | $75.00M | $75.00M | $170.11M | $99.14M | $167.79M | $170.93M | $74.99M | $150.00M | $75.00M | $150.00M |
| QoQ Change | — | -40.0% | +0.0% | -100.0% | — | — | — | +0.0% | +0.0% | +100.0% | -50.0% | +0.0% | +126.8% | -41.7% | +69.2% | +1.9% | -56.1% | +100.0% | -50.0% | +100.0% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | -0.0% | — | — | — | +0.0% | +0.0% | +126.8% | -33.9% | +123.7% | +127.9% | -55.9% | +51.3% | -55.3% | -12.2% |